完整後設資料紀錄
DC 欄位語言
dc.contributor.authorChou, Hsin-Chuan
dc.contributor.authorLin, Ching-Wei
dc.contributor.authorCheng, Ching-Hsue
dc.date.accessioned2009-06-02T06:40:29Z
dc.date.accessioned2020-05-25T06:42:19Z-
dc.date.available2009-06-02T06:40:29Z
dc.date.available2020-05-25T06:42:19Z-
dc.date.issued2006-10-11T08:07:51Z
dc.date.submitted2004-11-15
dc.identifier.urihttp://dspace.lib.fcu.edu.tw/handle/2377/1044-
dc.description.abstractKnowledge of medicinal chemical compounds is complex and evidence-based. In this paper, knowledge of drugs was extracted from experts, and evaluated with sophisticated computation techniques to perform critical decision making. Fuzzy inference system plays an important role in the artificial intelligence arena. So this paper utilized Mamdani fuzzy inference system to evaluate new drug candidates in efficient way by considering not only safety and efficacy, but also the hottest issue -cost. Though there have been studies relevant to decision making regarding drugs in medical institutions, none have utilized fuzzy computation approaches. The process this paper utilized here was also based on consensus of Drugs and Therapeutic Committee. Further more, the verification and comparison of this paper provide an intuition for system development and further researches.
dc.description.sponsorship大同大學,台北市
dc.format.extent6p.
dc.format.extent326290 bytes
dc.format.mimetypeapplication/pdf
dc.language.isozh_TW
dc.relation.ispartofseries2004 ICS會議
dc.subjectfuzzy logic
dc.subjectdrug
dc.subjecthealthcare
dc.subject.otherArtificial Intelligence
dc.titleEvaluating New Drugs by Fuzzy Inference System
分類:2004年 ICS 國際計算機會議

文件中的檔案:
檔案 描述 大小格式 
ce07ics002004000135.pdf318.64 kBAdobe PDF檢視/開啟


在 DSpace 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。